Evaluation of two mutants of Mycobacterium avium subsp. paratuberculosis as candidates for a live attenuated vaccine for Johne's disease.
about
Development of vaccines to Mycobacterium avium subsp. paratuberculosis infectionOn deaf ears, Mycobacterium avium paratuberculosis in pathogenesis Crohn's and other diseasesA rational framework for evaluating the next generation of vaccines against Mycobacterium avium subspecies paratuberculosis.Evaluation of a Salmonella vectored vaccine expressing Mycobacterium avium subsp. paratuberculosis antigens against challenge in a goat modelMutations in Ehrlichia chaffeensis Causing Polar Effects in Gene Expression and Differential Host SpecificitiesCrohn's disease and Mycobacterium avium subsp. paratuberculosis: the need for a study is long overdue.Phenotype and Function of CD209+ Bovine Blood Dendritic Cells, Monocyte-Derived-Dendritic Cells and Monocyte-Derived Macrophages.Evaluation of a Mycobacterium avium subsp. paratuberculosis leuD mutant as a vaccine candidate against challenge in a caprine modelCharacterization and expression of monoclonal antibody-defined molecules on resting and activated bovine αβ, γδ T and NK cellsSuperior Protection from Live-Attenuated Vaccines Directed against Johne's Disease.Bacteria-mediated disease therapy.Bovine paratuberculosis: recent advances in vaccine development.Genetic variations in the SPP1 promoter affect gene expression and the level of osteopontin secretion into bovine milk.Deletion of relA abrogates the capacity of Mycobacterium avium paratuberculosis to establish an infection in calves.Host responses to persistent Mycobacterium avium subspecies paratuberculosis infection in surgically isolated bovine ileal segments.Controlling Johne's disease: vaccination is the way forward.Pathogenesis, Molecular Genetics, and Genomics of Mycobacterium avium subsp. paratuberculosis, the Etiologic Agent of Johne's Disease.Knowledge gaps that hamper prevention and control of Mycobacterium avium subspecies paratuberculosis infection.Protein Kinase G Induces an Immune Response in Cows Exposed to Mycobacterium avium Subsp. paratuberculosis.A Mycobacterium avium subsp. paratuberculosis relA deletion mutant and a 35 kDa major membrane protein elicit development of cytotoxic T lymphocytes with ability to kill intracellular bacteria.
P2860
Q26739197-0E85D9C7-051E-41F3-BB43-F5DC0A531876Q26771203-FF8A4106-EBAF-4025-A638-AA528F9ECA82Q34154197-4E6048EC-B21F-4135-83B3-88B590B08A69Q34946514-200F5A19-E41C-43DB-BE6D-3C8787AA2129Q35694639-5DA2E5F4-E561-4606-92E8-90EEAF1B1E47Q35740246-109A4E5F-8414-40BC-98FF-58AC6D2CA567Q36169578-B3254257-9633-4D33-84D0-6AA3DC4E488EQ36757772-F0B591C4-B5DA-4898-BDBB-35870E66A110Q37397928-0484124C-A5AF-492F-B627-153525EA3865Q37563603-5CABCE7E-3BFC-46F9-ACA1-04FD12C2751AQ37950232-0079A665-C562-4A3F-B330-EC91CB2AF65AQ37955274-F33B5FD2-EA63-4A94-81DD-57513C7EF72FQ38981640-A8A64CA6-E608-4DB9-9C40-73D67FBFC0A3Q39852811-7C70D929-674B-45BA-963A-88D32719D039Q41983785-6C497CCE-2CFF-4A5C-88C5-3DFD54536E1AQ43113441-2FB59190-FDDB-482F-BBFC-4A2689126996Q46977882-37E67234-ADC4-483E-960D-5EBD59601676Q48301044-E7927D32-EE01-42BD-9FAB-CA045B44F289Q52723912-51B57113-3619-4A8B-8EC4-AD81E7EA0A50Q55446397-4555DD19-8D9F-4484-83E8-373B6550E9F4
P2860
Evaluation of two mutants of Mycobacterium avium subsp. paratuberculosis as candidates for a live attenuated vaccine for Johne's disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Evaluation of two mutants of M ...... d vaccine for Johne's disease.
@en
type
label
Evaluation of two mutants of M ...... d vaccine for Johne's disease.
@en
prefLabel
Evaluation of two mutants of M ...... d vaccine for Johne's disease.
@en
P2093
P2860
P50
P1433
P1476
Evaluation of two mutants of M ...... d vaccine for Johne's disease.
@en
P2093
Amanda Grimm
Andrew J Allen
Heba M Rihan
Keun Seok Seo
Mary J Hamilton
William C Davis
P2860
P304
P356
10.1016/J.VACCINE.2011.04.090
P407
P577
2011-05-10T00:00:00Z